Fig. 8
From: Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance
Nuclear basic fibroblast growth factor (bFGF) expression is increased in a subset of triple-negative (TN) breast cancers post neoadjuvant chemotherapy treatment. bFGF immunohistochemistry was performed on matched tumor tissues obtained from a patient with TN breast cancer before (pre-chemotherapy) and after (post-chemotherapy) neoadjuvant chemotherapy (docetaxel/cyclophosphamide) treatment. Magnification ×200